Einstein in the Media | U.S./Global

How much dietary salt is necessary? NBC’s “The Today Show” features research by Michael Alderman, M.D., that found current salt guidelines may be too low for most Americans. The collaborative study by Dr. Alderman and researchers at the Copenhagen University Hospital found that the average daily sodium intake of most Americans (between around 2,600 milligrams to 5,000 milligrams daily) is actually associated with better health outcomes than many current recommended guidelines (below 2,300 mg/day). Dr. Alderman is distinguished university professor emeritus of epidemiology & population health and of medicine, and holds the Atran Foundation Chair in Social Medicine. (Wednesday, April 02, 2014)

More coverage on Dr. Alderman | Dr. Alderman's Profile

 
 

In a Nautilus profile, Dr. William Jacobs, Jr., discusses the key breakthroughs in his tuberculosis research and how losing his vision impacted his career path. The feature also includes an audio interview and animation of Dr. Jacobs talking about his shift from mathematics to bacterial genetics, his desire to help the underprivileged, and his goal to see the eradication of TB in his lifetime. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator. (Monday, March 31, 2014)

More coverage on Dr. Jacobs, Jr. | Dr. Jacobs' Profile

 
 

NBCNews.com interviews Lisa Shulman, M.D., about new CDC estimates that 1 in 68 children have autism, a 30 percent jump from the 2008 estimate. Dr. Shulman noted that clinicians are seeing and diagnosing more children who previously had more limited access to evaluation, such as Hispanics, African-Americans and children who do well in school. Dr. Shulman is associate professor of clinical pediatrics and director of infant and toddler services at Einstein’s Children’s Evaluation and Rehabilitation Center and an attending physician at The Children’s Hospital at Montefiore. (Thursday, March 27, 2014)

More coverage on this story | More coverage on Dr. Shulman | Dr. Shulman's Profile

 
 

Wall Street Journal features new research by Nir Barzilai, M.D. that found lower levels of growth hormone are associated with extended lifespan in centenarians. Concerns about the dangers of using human growth hormone (HGH) as an anti-aging agent—a growing $4 billion industry—are increasing. Dr. Barzilai notes hormones that might have some beneficial effect for children with stunted growth may have a negative effect on aging adults. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of Einstein's Institute for Aging Research. (Tuesday, March 25, 2014)

More coverage on Dr. Barzilai | Dr. Barzilai's Profile

 
 

The New York Times reports on research by David Stein, M.D., and a team of scientists that successfully used “gene editing” technology to alter people’s cells to resist HIV. The New England Journal of Medicine study suggests that by homing in on and disabling a specific gene, it may eventually be possible to treat HIV without the use of antiretroviral drugs. The research team was led by the University of Pennsylvania and included Sangamo BioSciences.  Dr. Stein is associate professor of clinical medicine at Einstein and director of Adult HIV Research at Jacobi Medical Center. (Thursday, March 06, 2014)

More coverage on this story | Dr. Stein's Profile

 
 

The BBC Radio 4 program More or Less, interviews Paul Marantz, M.D., M.P.H., about a widely reported study in the British Medical Journal that found “an apple a day” was as effective as statins in preventing death. Dr. Marantz asserts that the journal’s publicity for the paper, published as part of the BMJ’s traditionally lighthearted Christmas issue, oversimplifies the issue and misleadingly compares the results of rigorous clinical trials for statins with much weaker observational data about food intake. Dr. Marantz came to the attention of the BBC as a result of a post he authored for Einstein’s blog, The Doctor’s Tablet. Dr. Marantz is associate dean for clinical research education and professor of clinical epidemiology & population health and of clinical medicine. (Segment begins at 21:00 of “Obesity Crisis?” episode, January 17, 2014) (Tuesday, January 21, 2014)

More coverage on Dr. Marantz | Dr. Marantz's Profile

 
 

WNYC Radio interviews Edward Burns, M.D., about the planned budget deal could restore some funding to the National Institutes of Health. Dr. Burns notes that the sequester – which cut budgets between five to ten percent – was deadly for research and might even stop young scientists from pursuing a research career. Dr. Burns is executive dean and professor of pathology and of medicine. (Audio begins at 1:32) (Thursday, December 19, 2013)

More coverage on Dr. Burns | Dr. Burns' Profile

 
 

NBC News features Ekaterina Dadachova, Ph.D., and her focus on radioimmunotherapy. Preclinical research shows it has the potential to eradicate HIV. The research, which uses radioactive isotopes to target cells, tested radioimmunotherapy on human blood samples and a laboratory model of the blood-brain barrier constructed of human cells. Dr. Dadachova is professor of radiology and of microbiology & immunology and the Sylvia and Robert S. Olnick Faculty Scholar in Cancer Research. (Friday, December 06, 2013)

More coverage on this story | Dr. Dadachova's Profile

 
 

The Wall Street Journal highlights groundbreaking research by Steven Walkley, D.V.M., Ph.D., that has led to treatment options for the rare condition Niemann-Pick Type C. In a lengthy cover story covering at least six years of reporting, journalist Amy Marcus details the passion that drove Walkley to continue his research on the drug cyclodextrin – and explores how parents and scientists have joined forces to find more effective treatments. (Thursday, November 14, 2013)

See Multimedia Version of this Feature | More coverage on Dr. Walkley | Dr. Walkley's Profile

 
 

The Scientist profiles Ana Maria Cuervo, M.D., Ph.D., detailing her career path and research in autophagy. The career retrospective follows Dr. Cuervo’s career from her first medical student project in Spain to her arrival at Einstein. Dr. Cuervo is professor of developmental and molecular biology, of anatomy and structural biology, and of medicine and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein. (Friday, November 01, 2013)

More coverage on Dr. Cuervo | Dr. Cuervo's Profile

 
 

BBC News interviews Harry Ostrer, M.D., and The New York Times cites research by Gil Atzmon, Ph.D., in two articles about a new study on Jewish genetic history. The new study analyzed mitochondrial DNA, genetic information inherited through women, and found that at least 80 percent of Ashkenazi maternal ancestry hailed from Europe, not the Middle East, suggesting that many European Jewish communities were founded by men who married and converted local women. Dr. Ostrer is professor of pathology, of genetics and of pediatrics at Einstein and director of genetic and genomic testing at Montefiore Medical Center. Dr. Atzmon is associate professor of medicine and of genetics. (Wednesday, October 09, 2013)

More coverage on this story | More coverage on Dr. Ostrer | More coverage on Dr. Atzmon | Dr. Ostrer's Profile | Dr. Atzmon's Profile

 
 

NPR interviews Johanna Daily, M.D., about the new, modestly effective RTS,S malaria vaccine that reduced disease in children by 27-46 percent. Dr. Daily notes that while higher efficacy rates are desirable, malaria is a particularly challenging disease that researchers have struggled to prevent. She explains that each country that battles with malaria will have to choose how to spend their limited resources – on this vaccine, protective nets, community health workers or other options. Dr. Daily is associate professor of medicine and of microbiology & immunology. (Tuesday, October 08, 2013)

More coverage on Dr. Daily | Dr. Daily's Profile

 
 

CBSNews.com interviews Lou Weiss, M.D., M.P.H., about a new blood test that determines whether a person's respiratory illness is caused by virus or bacteria. Dr. Weiss explains that the test, which provides results in only 12 hours, has the potential to be extremely beneficial because it can help with diagnosis and prevent doctors from giving unnecessary antibiotics, which drives the growing problem of antibiotic resistance. Dr. Weiss is professor of pathology and of medicine at Einstein. (Tuesday, September 24, 2013)

More coverage on Dr. Weiss | Dr. Weiss' Profile

 
 

The New York Times' Science Times section interviews Jean Hébert, Ph.D., about his research featured in Science that found a link between hyperactivity and an inner ear defect in mice. Because the study was preliminary, Dr. Hébert cautions that parents should not start testing their hyperactive children for hearing loss. Dr. Hébert is professor in the Dominick P. Purpura Department of Neuroscience and of genetics. (Monday, September 09, 2013)

More coverage on this story | Dr. Hébert's Profile

 
 

The Wall Street Journal interviews Max O’Donnell, M.D., for a front-page story on a TB “hotbed” that developed in a South African prison. Dr. O’Donnell notes that poor monitoring and crowded conditions can result in the disease “spiraling out of control.” Dr. O’Donnell is assistant professor of medicine and of epidemiology & population health at Einstein. (Thursday, August 08, 2013)

Dr. O'Donnell's Profile

 
 
First Page | Previous Page | Page of 13 | Next Page | Last Page